A method for producing a Guerbet alcohol, including reacting a raw material alcohol having 8 or more and 22 or less carbon atoms, in the presence of a catalyst (A) containing a first component, a second component, and a third component below: first component: copper, second component: one kind selected from the group consisting of cobalt, nickel, molybdenum, and rhenium, and third component: at least one kind selected from the group consisting of elements that are elements belonging to Groups 3 to 10 and 12 of the fourth period of the periodic table and elements belonging to Groups 3 to 7, 11, and 12 of the fifth and sixth periods of the periodic table, and are different from the element selected as the second component.

A method for producing a Guerbet alcohol, including reacting a raw material alcohol having 8 or more and 22 or less carbon atoms, in the presence of a catalyst (A) containing a first component, a second component, and a third component below: first component: copper, second component: one kind selected from the group consisting of cobalt, nickel, molybdenum, and rhenium, and third component: at least one kind selected from the group consisting of elements that are elements belonging to Groups 3 to 10 and 12 of the fourth period of the periodic table and elements belonging to Groups 3 to 7, 11, and 12 of the fifth and sixth periods of the periodic table, and are different from the element selected as the second component.

The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

The present application relates to a compound of the following formula (I)

##STR00001## in which —R.sup.1, R.sup.2, R.sup.3 and R.sup.4 represent independently of each other H or a (C.sub.1-C.sub.30) alkyl group, the total sum of the number of carbon atoms of R.sup.1, R.sup.2, R.sup.3 and R.sup.4 being equal to 6+4x, x being a whole number of between 1 and 6, provided that: at most two of the groups R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are H, R.sup.5 represents H, OR, or NR′R″ R, R′ and R″, identical or different, represent H, a (C1-C10) alkyl group, at least one of groups R.sup.1, R.sup.2, R.sup.3 or R.sup.4 comprises or is a tertiobutyl group. (I) the method for preparing same and the uses thereof as a plasticising lubricant, surfactant or in a cosmetic composition.

The present application relates to a compound of the following formula (I)

##STR00001## in which —R.sup.1, R.sup.2, R.sup.3 and R.sup.4 represent independently of each other H or a (C.sub.1-C.sub.30) alkyl group, the total sum of the number of carbon atoms of R.sup.1, R.sup.2, R.sup.3 and R.sup.4 being equal to 6+4x, x being a whole number of between 1 and 6, provided that: at most two of the groups R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are H, R.sup.5 represents H, OR, or NR′R″ R, R′ and R″, identical or different, represent H, a (C1-C10) alkyl group, at least one of groups R.sup.1, R.sup.2, R.sup.3 or R.sup.4 comprises or is a tertiobutyl group. (I) the method for preparing same and the uses thereof as a plasticising lubricant, surfactant or in a cosmetic composition.

The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

The present disclosure pertains to a new synthetic method for the preparation of 2-methyl-2-hydroxyheptane and 2-methyl-2-alkoxyheptanes, which are valuable commodities for use in flavors, fragrances and various personal care products, such as cosmetics.

The present disclosure pertains to a new synthetic method for the preparation of 2-methyl-2-hydroxyheptane and 2-methyl-2-alkoxyheptanes, which are valuable commodities for use in flavors, fragrances and various personal care products, such as cosmetics.